Ionis Pharmaceuticals Inc. Common Stock vs Nokia Corp — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.28 (market cap $7.10B), while Nokia Corp trades at $9.31 (market cap $54.48B). The key difference: Nokia Corp is far larger — about 7.7× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Nokia Corp pays a 1.74% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Nokia Corp for 65 Days on average.
| IONS | NOK | |
|---|---|---|
Market Cap | $7.10B | $54.48B |
Volume | 2,027,457 | 85,996,980 |
Sector | Health | Technology |
52-Week High | $86.50 | $16.83 |
52-Week Low | $42.38 | $5.55 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $6.66B | $52.50B |
Dividend Yield | — | 1.74% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →